TERM SHEET BY AND BETWEEN PLURISTEM LTD. AND SOSEI CORPORATE VENTURE CAPITAL LTD. WITH RESPECT TO ESTABLISHMENT AND OPERATION OF A JOINT VENTURE December 19, 2016Pluristem Therapeutics Inc • February 8th, 2017 • Biological products, (no disgnostic substances) • New York
The Transaction: The parties shall establish and operate a joint venture in Japan in order to commercialize and bear responsibility for all marketing, distribution, clinical and regulatory development of Pluristem's proprietary PLX-PAD cells based product (The "Product") for the Indication (the "Indication") in the Territory (the "Transaction" and the "Purpose").
